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Basic leucine-zipper (bZIP) proteins reside at the end of cell-signalling cascades and function to 
modulate transcription of specific gene targets. bZIPs are recognised as important regulators of 
cellular processes that include cell growth, apoptosis and cell differentiation. One such validated 
transcriptional regulator, Activator Protein-1 is typically comprised of heterodimers of Jun and 
Fos family members, and is key in the progression and development of a number of different 
diseases. The best described component, cJun is upregulated in a variety of diseases that include 
cancer and osteoporosis and psoriasis. Towards our goal of inhibiting bZIP proteins implicated in 
disease pathways, we here describe the first use of a novel in silico peptide-library screening 
platform that facilitates the derivation of sequences exhibiting high affinity with cJun while 
disfavouring homodimer formation or formation of heterodimers with other closely related Fos 
sequences. In particular, using Fos as a template, we have computationally screened a peptide 
library of over 60 million members and ranked hypothetical on/off target complexes according to 
predicted stability. This resulted in the identification of a sequence that bound cJun, but 
displayed little homomeric stability or preference for cFos. The computationally selected 
sequence maintains similar interaction stability to a previous experimentally derived cJun 
antagonist, while providing much improved specificity. Our study provides new insight into the 
use of tandem in silico screening / in vitro validation and the ability to create a peptide that is 
capable of satisfying conflicting design requirements. 
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INTRODUCTION 
Coiled coils (CCs) are located within 3-5% of all amino acid structures and are highly versatile in the 
interactions they drive. They are characterised by a repeat of seven amino acids, the heptad repeat, 
with a preference for particular residue types at each position1. Despite the apparent 
straightforward link from their primary sequence to quaternary structure, CCs are highly specific in 
driving a wide variety of diverse protein-protein interactions, making them highly relevant systems 
in biotechnology and synthetic biology, and as pharmacological targets. Parallel dimeric CCs 
structures found within bZIP (basic leucine zipper) motifs are one of the simplest examples – it is 
comprised of 2 left-handed supercoiled α-helices which intertwine via a large interacting surface 
area.  
Efforts are on-going to be able to predict bZIP stability2–5, and more recently specificity2,4,6–8. The 
ability to predict stability and specificity of peptides directly from the primary structure is a 
longstanding goal, and is particularly important given the large number of human bZIPs. Current 
attempts to design peptides that specifically inhibit target leucine zipper interactions have taken a 
incremental library-based approach, with each new attempt increasing our understanding of the 
factors that underpin overall affinity. For example, in vitro assays of the binding affinity of 53 human 
bZIPs1 showed there to be multiple interaction profiles, with specificity both within and between 
discrete bZIP families. This amounts to over 1400 potential interactions and selectivity within this set 
of bZIP interactions demonstrates how inherent sequence elements govern the selectivity of CC 
interactions. We have previously utilised an intracellular library screening approach to derive specific 
antagonists of the oncogenic transcriptional regulator, Activator Protein-1 (AP-1).  
Transcription factors represent compelling if difficult drug-targets by conventional small molecule 
approaches. Their modulation can ensure that erroneous signals can be blocked at the 
transcriptional level, thus halting production of target genes implicated in disease, irrespective of the 
upstream signal imposed. Indeed, many oncogenic signal transduction cascades are known to 
upregulate transcription factor activity, leading to gene expression changes that drive cell 
transformation9-10 and that place bZIP families centre stage as therapeutic targets in cancer. Our 
previous efforts in this area have resulted in antagonism of AP-1 components by designing Jun or 
Fos-based peptide libraries. This has been followed by their expression and screening inside living 
cells for an interaction with their target protein3,11,12. In addition, we have experimented with 
methodologies in which competing off-target proteins are expressed in the assay during library 
selection. Both our conventional intracellular Protein-fragment Complementation Assay (PCA) library 
screening approach3,11 as well as a target-specificity enhancing Competitive and Negative Design 
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Initiative (CANDI)13 have resulted in a many PPI inhibitors14,15  and CC forming peptides in which the 
target is sequestered from binding to its natural partner. These assays have the significant advantage 
over in vitro approaches, of enriching for target-specific sequences (relative to a broad range of 
other proteins expressed within the cell), as well as sequences that are structured, soluble, non-
toxic, and that resist protease breakdown. Moreover the significant amount of data gained from 
these experiments, and our consequent increased understanding of the system, has facilitated the 
development of a series of tools that can work by predicting the affinities, and consequently 
specificities of CCs, based only on input of the primary amino acid sequences.  
The bZIP CC Prediction Algorithm (bCIPA)3,16 works by analysing the helical propensities of 
component helices, together with the predicted contribution from electrostatic interactions and 
core residue interactions, to estimate the thermal denaturation temperature (Tm) of all hypothetical 
dimeric species within a defined system. Driven by coupling energies that describe ai-a'I hydrophobic 
interactions and gi-e’i+1 electrostatic interactions, as pairwise interactions measured by previous 
double mutant analysis studies in CCs17,18. bCIPA was derived to estimate the Tm of a given parallel 
dimeric CC using only the primary sequence and was shown to correctly predict 97% of all strong 
interactions and 95% of all non-interacting pairs using an independent data set of human bZIP 
proteins.  As with previous prediction models, this approach allows prediction in a pairwise manner.  
From previous work conducted to benchmark the accuracy of various prediction approaches using 
binding data from a FRET assay of interacting bZIP proteins 19, bCIPA has similar accuracy to other 
purely data-driven models2,18 and had more prediction accuracy for the 948 experimentally derived 
binding values than models which were driven solely by (or in combination with) CC structural 
prediction20,21. Indeed, using the bCIPA engine we have recently screened very large peptide 
interactomes to identify sets of up to sixteen de novo designed peptides that when combined are 
capable of forming specific CCs with their cognate partners6,7.  
Building on these previous findings, here we describe our efforts to take the approach much further 
by describing the first utilisation of an in silico approximation to the PCA and CANDI-PCA approach, 
which we term in silico PCA (isPCA) and in silico CANDI (isCAN). The first approach allows the user to 
i) define a target ii) define every library member as a potential homodimeric off-target (Fig 1). The 
isCAN approach brings the additional capability of iii) entering user-defined sequences that can 
interact with either the target or library member. Both isPCA and isCAN allows the user to create 
and in silico screen a much more expansive library than is accessible experimentally using either the 
complementary intracellular PCA or CANDI-PCA approaches (i.e. ~107 for isCAN vs. ~105 for PCA). The 
software then selects sequences on the basis of the greatest ΔTm between all non-desired states and 
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the desired target interaction, to give the highest predicted specificity. Here we describe the first 
implementation of the isCAN approach and provide an experimental validation of its use by 
computationally screening over 60 million peptides to identify candidates that can bind to cJun 
specifically in the presence of cFos.  
Figure 1 –  Overview of the CANDI 
protocol. Shown are the desired 
and numerous undesired states 
that can form upon combination of 
the library/target/competitor 
peptides. Complexes 1, 2 (negative) 
and 5 (desired) are found within 
PCA, with the competitor 
complexes (4 and 5) introduced in 
CANDI. Within isCAN, specificity is 
driven by the desired delta value as 
specified by the user. The library 
member is only successful if it is 
able to form the desired complex 
with predicted Tm values greater 
than the delta. 
 
Materials and Methods 
In silico CANDI-PCA (isCAN) computationally screens a user-defined library against a given target. It 
identifies the highest predicted affinity binder to have greatest difference between target and off-
target stability. This includes library homodimers as well as user-defined off-targets. isCAN utilises 
the underlying bCIPA algorithm2-3, which incorporates Helical Propensity (HP), Core (C) and 
Electrostatic interactions (ES) to provide a quantitative estimate of the interaction affinities in the 
form of a thermal melting temperature (Tm) as follows: 
𝑇𝑚 = (𝑎 ×  𝐻𝑃) + (𝑏 ×  𝐶) + (𝑐 ×  𝐸𝑆) +  𝑑      (1) 
The various functions within the algorithm assign scores to the peptide-peptide interactions. The 
size of the coefficients (a = 81.3256, b = -10.5716, c = -4.7771 and d= -29.1320) acts as a modifier for 
Negative	 Competitive	
Desired	
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the scale of the score.  For the calculation of HP, the average α-helical propensity4 of both peptides 
are calculated and totalled in Equation 2: 
𝑓(𝐻𝑃)  =  (𝛴ℎ𝑝𝑎[𝑙]  +  𝛴ℎ𝑝𝑏[𝑙])   (2) 
The nature of the frame alignment that bCIPA employs ensures that, if the peptides are not of same 
length, helical propensity is calculated to the length of the shorter peptide (l). For the calculation of 
the core interactions, only the residues within the hydrophobic interior (i.e. ‘a’ or ‘d’ positions) are 
considered such that the scoring mechanism is calculated accordingly: 
𝑓(𝑐𝑜𝑟𝑒)  =  (𝛴𝑐𝑜𝑟𝑒𝑟𝑒𝑠  ×  𝑦)     (3) 
The format of this function is such that the non-considered residues are calculated but are 
disregarded (y = 0) . Only for the ‘a’ and ‘d’ positions is the value of y set to 1 (otherwise set to 0), 
ensuring that the core value in the final Tm calculation only incorporates these two heptad locations. 
As shown in Equation 4, only positions ‘e’ and ‘g’ are considered in an gi-ei+1 parameter when 
calculating the electrostatic parameters: 
𝑓(𝐸𝑆)  =  (𝛴𝑒𝑠𝑟𝑒𝑠)      (4) 
The program scans either peptide to calculate an electrostatic score for gi-ei+1  and ei-gi-1. This 
ensures that, even in the case of different length peptides, all of the potential electrostatic 
interactions are taken into account in the final ES score without unnecessarily incorporating a 
substituent score more than once.  
Although the bCIPA engine has been previously employed to provide an in silico interactome 
prediction algorithm for the derivation of heterospecific coiled coil sets6,7 all previous 
implementations of bCIPA have been restricted to estimating the Tm for single pairs of peptides 
forming a CC. Considering the ability that the algorithm displayed in accurately distinguishing 
interacting from non-interacting CCs, the logical next step was to expand its remit to mirror the 
semi-rational design and screening approach used in an experimental setting. isCAN simulates the 
CANDI extension of the PCA screening technique, and is a more advanced application of the bCIPA 
algorithm. The CANDI application of PCA involves the addition of competing peptides13. If the target 
or the library member favour complexes with the competitor peptide, cell growth is either reduced 
or halted (. 1). Similarly, isCAN is able to consider multiple off-targets in addition to the target. To 
achieve this, in addition to in-built frame alignment and prediction functions, isCAN has a number of 
unique in-built check points. These make use of the individual predictions relating to the library (L), 
target (T) and competitor (C) peptides.  Due to the optimisation of core and electrostatic residues 
found in designed libraries, many peptides members are predicted to be more stable as 
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homodimeric complexes than as heterodimers with the target. isCAN is split into two sections – with 
the first set of calculations mirroring the PCA (isPCA section) and the second introducing the 
competitor peptides (isCAN). This stepwise calculation ensures that processing time is not wasted on 
library members which are predicted to preferentially homodimerise or are unable to overcome the 
target homodimer (and are therefore not “PCA successful”).  A key concept in both is the predicted 
difference in Tm values (Δ). It is the key determinant behind the separation of successful and 
unsuccessful peptides in the library. User-defined, this value underlies all of the check-points that 
the software considers.  In particular, if TmL-T – TmL-L > Δ (i.e. the difference between the L-T desired 
heterodimer and the library homodimer is greater than the previously established desired delta 
value), then the peptide is considered homodimerically successful and proceeds to the subsequent 
stages. Any peptides that meet both this and the target homodimer delta (TmL-T – TmT-T > Δ) are 
considered “PCA-successful” (i.e. complying with the scenario found during a PCA).  The PCA-
succesful library members then have their desired state Tm (TmL-T) compared with CANDI-specific 
competitive library off-target Tm values (i.e. TmL-T – TmT-C > Δ and TmL-T – TmL-C > Δ) and the ‘CANDI-
successful’  library members are next exported for further analysis. Due to the multiple ways in 
which AP-1 may actively form, users can enter other Fos and Jun family member sequences to 
impose target-specificity upon the screen. This addresses one of the key points of computationally 
aided peptide design with large families of peptides – avoiding interactions with other bZIPs which 
may be transcriptionally active and beneficial.  
Calculating off-targets - In any simulated CANDI system, the interactions can be expressed as 2n+3 
where n refers to the number of peptides introduced as competitive molecules, with only one 
desired (L-T) interaction.  As an example, a cJun-targeting library would utilise four Fos family 
members (cFos, FosB, Fra1,Fra2) as competitors. As previously mentioned, this would result in 10 
off-targets for each peptide. As such, this would be 10 Tm values that the single desired L-T complex 
Tm must be able to overcome with Δ > 0. To maximise the efficiency of the tool, the initial 
calculations made by the prediction software are of the heterospecific (L-T) complex. The output of 
this simple screen is used to partition the library by desired Tm, irrespective of the ability to 
outcompete predicted off-target complexes. These partitions are 106 in size and are used to break 
down the computationally expensive isCAN calculations into computationally less demanding 
processes - approximately 36000 calculations are processed in one minute (with this value increasing 
over time as increasing amounts of calculation data is stored within the application).  
Peptide Synthesis - Rink amide ChemMatrix™ resin was obtained from PCAS Biomatrix, Inc. (St.-Jean-
sur-Richelieu, Canada); Fmoc L -amino acids and 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetra-
methyluronium hexafluorophosphate or benzotriazol-1-yl-ox-ytripyrrolidinophosphonium 
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hexafluorophosphate were obtained from AGTC Bioproducts (Hessle, UK); all other reagents were of 
peptide synthesis grade and obtained from ThermoFisherScientific (Loughborough,UK). 
Peptides were synthesised on a 0.1-mmol scale on a PCAS ChemMatrix™ Rink amide resin using a 
Liberty Blue™ microwave peptide synthesiser (CEM; Matthews, NC) employing Fmoc solid-phase 
techniques22 with repeated steps of coupling, deprotection and washing (4 × 5 ml 
dimethylformamide).  
Coupling was performed as follows: Fmoc amino acid (5 eq), 2-(1H-benzotriazole-1-yl)-1,1,3,3 
tetramethyluronium hexafluorophosphate or benzotriazol-1-yl-oxytripyrrolidinophosphonium 
hexafluorophosphate(4.5 eq) and diisopropylethylamine (10 eq) in dimethylformamide (5 ml) for 5 
min with 35-W microwave irradiation at 90 °C.  
Deprotection was performed as follows: 20% piperidine in dimethylformamide for 5 min with 30-W 
microwave irradiation at 80 °C. Following synthesis, we acetylated the peptide—acetic anhydride (3 
eq) and diisopropylethylamine (4.5 eq) in dimethylformamide(2.63 ml) for 20 min—and then cleaved 
it from the resin with concomitant removal of side-chain-protecting groups by treatment with a 
cleavage mixture (10 ml) consisting of TFA (95%), triisopropylsilane (2.5%) and H2O (2.5%) for 4 h at 
room temperature. 
Suspended resin was removed by filtration, and the peptide was precipitated using three rounds of 
crashing in ice-cold diethyl ether, vortexing and centrifuging. The pellet was then dissolved in 
1:1MeCN/H2O and freeze-dried. Purification was performed by RP-HPLC using a Phenomenex Jupiter 
Proteo (C18) reverse-phase column (4 μm, 90 Å, 10 mm inner diameter × 250 mm long). Eluents 
used were as follows: 0.1% TFA in H2O (a) and 0.1% TFA in ACN (b). 
The peptide was eluted by applying a linear gradient (at 3.5 ml/min) of 5–95% B over 40 min. 
Fractions collected were examined by electrospray MS, and those found to contain exclusively the 
desired product were pooled and lyophilised. Analysis of the purified final product by RP-HPLC 
indicated a purity of >95%. 
Circular Dichrosim (CD) was carried out using an Applied Photophysics Chirascan CD apparatus 
(Leatherhead, UK) using a 200-μl sample in a CD cell with a 1-mm path length. Samples contained 
150 μM total peptide (Pt) concentration at equimolar concentration for heterodimeric solutions (i.e., 
75 μM per peptide) and suspended in 10 mM potassium phosphate and 100 mM potassium fluoride 
at pH 7 for 30 minutes prior to analysis. The CD spectra of samples were scanned between 300 nm 
and 190 nm in 1 nm steps, averaging 0.5 s at each wavelength. Three scans at 20 °C were averaged 
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to assess helical levels and CC structure. Raw data (ellipticities) were collected and averaged, and 
data were converted to molar residue ellipticities (MRE). 
Thermal denaturation experiments were performed at 150 μM in a buffer of 10 mM potassium 
phosphate and 100 mM potassium fluoride at pH 7. The instrument used was an Applied 
Photophysics Chirascan Circular Dichroism device. For all thermal denaturation experiments, a 
stepping gradient was set from 0°C to 90°C in 1°C increments (except for cFos containing complexes 
– which stopped at 50°C). Each temperature point was held for 0.5 min to equilibrate sample before 
scanning ellipticity at 222 nm. Melting profiles converted to equilibrium denaturation curves fitted 
to a two-state model, derived via modification of the Gibbs–Helmholtz equation to yield the melting 
temperature (Tm).23  
Size-exclusion experiments chromatography experiments were performed at room temperature 
using a Superdex Peptide 10/300 GL column (GE Healthcare Life Sciences) by injecting 100 μl of a 
150 μM Pt sample in 10 mM potassium phosphate and 100 mM potassium fluoride at pH 7 and at a 
flow rate of 0.5 ml/min. Elution profiles were recorded via A280. 
 
Results and Discussion 
cFos based Library Generation. We previously utilised a number of in vitro12,16 and in cellulo3,11 
peptide library screening approaches to derive sequences capable of binding to the cJun target of 
AP-1. One of these efforts utilised a PCA approach with a library of 62,000 members to result in a 37 
residue cJun antagonist (FosW)3. Using FosW as a template for further library design, this was 
followed by a truncated variant, 4HFosW, that retained most of the interaction affinity11. More 
recently we have taken this further by rationally designing helix-constrained variants to permit 
downsizing of the molecule while retaining binding affinity24. As a mechanism for further increasing 
target selectively during selection we have also expressed off-target homologous sequences during 
PCA selection. The CANDI-PCA approach works by maximising the difference in free energy of 
binding between the target and off-target complexes by removing non-selective library members13.  
Here we present a powerful new approach, based on the bCIPA engine, to facilitate the in 
silico derivation of specific peptide antagonists. As an exemplar we have derived a  39-residue 
antagonist that is specific for the cJun target. The sequence incorporates two additional residues 
over earlier designs - one g one e residue located at the N-terminus and C-terminus respectively (Fig. 
2A). These permit four additional electrostatic interactions and in doing so provide greater scope for 
stabilisation/destabilisation of target/off-target complexes to enhance interaction specificity. Using 
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this extended cFos sequence as our design scaffold (Fig. 2A), we have implemented an in silico 
approximation to the PCA and CANDI-PCA in cellulo screening systems to allow a rapid prediction of 
peptide sequences that display high target specificity. The tools described in this study are freely 
available (see supporting information). 
 
Figure 2 – Design of peptide inhibitor sequences (a). Peptide options are randomised around g/e 
positions (p) and a position (h). Compared to previous designs, the FosUisCAN has had extensions 
added at N-terminal and C-terminal positions to add 2 extra residues for extra electrostatic 
interactions. The helical wheel diagrams, generated with DrawCoil 1.05, (b-d) display the residues 
present on the coiled coil from the position of the N-terminus to the C-terminus, looking down the 
axis of the alpha helices. These diagrams illustrate the hydrophobic interface at the core position 
(a/d) and the charged residues present at the flanking position (e/g). The repulsive residues found at 
the electrostatic positions in off-target complexes (b and d) are selected.  The helical wheel of 
FosUisCAN – cJun (c) demonstrates how FosUisCAN has favourable electrostatic and core interactions to 
drive coiled coil formation. 
 
A	 B	
C	 D	
g abcdefg abcdefg abcdefg abcdefg abcde
L TDTLQAE TDQLEDE KYALQTE IANLLKE KEKLE
  LDELQAE IEQLEER NYALRKE IEDLQKQ LEKL
  LDELQAE IEQLEDQ NYALQKE VEDLRKE LEKL
  LDELQRE IEQLEEL NYALQKE IEDLQKQ
R IARLEEK VKTLKAQ NYELAST ANMLREQ VAQLK 
p hDTLpAp hDQLpDp hYALpTp hANLpKp hEKLp 
Q IDTLEAE IDQLEDE NYALETE IANLEKE IEKLE
cFos:
FosW:
FosWCANDI:
4hFosW:
cJun:
Lib:
FosUisCAN:	
 10 
During library generation, each position was inspected and options placed into the library 
sequence that corresponded to core hydrophobic and electrostatic positions within the heptad 
repeats (a, e and g). This resulted in an in silico library size of 60,466,176 peptides  (a = ILVN, e = 
QEK, g = QEK, with N included at all a positions to give rise to potential specificity driving N-N pairs 
with the a3 position on the target helix and to mitigate against the formation of higher-order 
oligomers 25–28. The predicted ΔTm parameter (defined as the difference between the Tm of desired 
dimer and closest non-desired dimer) was set to 20°C during parameter initialisation, since this was 
found to be the lowest value that resulted in a library able to be screened within a reasonable 
timeframe while retaining a large number of peptides predicted to be successful, such that library 
diversity was retained. We followed only members of the top 106 (partition 1) following these initial 
calculations, as this provided computationally efficiency (reducing calculation time from ~3 days to 5 
hours - see supporting information) whilst selecting library members of the highest predicted target 
affinity. This step reduced the expansivity of the search prior to entry into the more stringent isCAN 
step, which additionally considered members of the cFos family that naturally interact with cJun (i.e. 
cFos, FosB, Fra1, Fra2) as explicit off-targets. As a competitive step in the initial isPCA, additional 
consideration of potential library members as homodimers and the stability of the cJun target as a 
homodimer were simulated (Fig. 1). During this step, many peptides formed predicted homodimers 
or were not suitably more stable than the predicted Tm of the homodimeric cJun target complex, and 
were consequently unable to overcome the stringent desired ΔTm. Once the isPCA section was 
completed, the 60,466,176 member library was reduced to 73,124 peptides – a reduction to 0.12% 
of the original library. The predicted ΔTm values for the PCA complexes drove this reduction, i.e. the 
difference between Library–cJun (L–T), and cJun–cJun (T–T) or Library–Library (L–L) interactions. 
Each successful peptide in the pool that satisfied the ΔTm parameter set was permitted to proceed. 
These were described as sequences with predicted Tm values for non-desired states (TmL-L and TmT-T) 
of at least 20°C less than the predicted Library-cJun Tm (TmL-T). These “isPCA-successful” peptides 
were next entered into isCAN. This final step introduced simulated competitors (in this case 
members of the Fos family that are known to form transcriptionally active complexes with cJun: 
cFos, FosB, Fra1 and Fra2). The isCAN step reduced the remaining library size further to 71,667 
peptides. The isCAN step was critical in removing 1457 members that were predicted to bind to one 
of the Fos off-target competitor peptides (TmL-C). These were again defined as those unable to 
overcome the required ΔTm values between the Library-cJun (TmL-T), the target – competitor complex 
((TmT-C) and Library –competitor (TmL-C) complexes. The average predicted ΔTm for all L-C complexes 
(292,496 interactions) was 11°C.  
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Peptide Selection - FosUisCAN. From the reduced size pool, peptides were finally ranked by the 
predicted ΔTm value according to isCAN. This ensured that the peptide chosen for further study 
(FosUisCAN) would exhibit both a high predicted TmL-T and a large ΔTm (i.e. >20 °C) between this and the 
most stable of off-targets. As shown in Table 1, the peptide pool was reduced further to generate 
the top 10 sequences ranked by ΔTm, which allowed for comparison of similarities and key 
differences between sequences.  
 
Table 1. Top 10 peptides ranked by ΔTm predictions calculated by isCAN screening, representing the 
top 0.01% of isCAN successful peptides . FosUisCAN6 was selected for validation (*and named 
FosUISCAN) due to the occurrence of Glu residues at g and e positions (in bold). These were predicted 
to have maximal beneficial interactions with cJun and maximal repulsion with off-targets (i.e. in 
complex with cFos and as a homodimer). Sequences additionally contain N-cap (AS) and C-cap (GAP) 
motifs not depicted here. 
 
These peptides represented the top 0.01% of all peptides to successfully emerge from isCAN. The 
final sequence, FosUisCAN6 (termed FosUisCAN) was selected for validation with the rationale that the 
high level of similarity between the 10 sequences and corresponding Tm values and ΔTm values from 
nearest stability off-targets.  The selected sequence was chosen on the basis of ‘charge blocks’ – 
blocks of basic or acidic side chains at e/g positions that contribute favourably to the overall ΔTm 6,7, 
but for which the sequence context of otherwise energetically equivalent residue contribution is not 
considered by the software (see also below). Additionally, the minimal difference between predicted 
isCAN	#	
Peptide	
	
p hDTLpAp hDQLpDp hYALpTp hANLpKp hEKLp
Library-
Target	
Tm	(°C)	
Library-
Library	
Tm	(°C)	
ΔTm	
1	 Q IDTLEAE IDQLEDK NYALKTE LANLEKE IEKLE 92.5	 39.3	 52.0	
2	 K IDTLEAE IDQLEDK NYALKTE IANLEKE IEKLE 94.2	 42.7	 51.5	
3	 Q IDTLEAE IDQLEDK NYALKTE IANLEKE IEKLE 91.9	 38.1	 51.0	
4	 K IDTLEAE IDQLEDK NYALKTE LANLEKE IEKLE 94.8	 43.9	 50.9	
5	 K IDTLQAE IDQLEDK NYALKTE IANLEKE IEKLE 91.1	 41.2	 49.8	
6*	 Q IDTLEAE IDQLEDE NYALETE IANLEKE IEKLE 91.3	 41.6	 49.7	
7	 K IDTLQAE IDQLEDK NYALKTE LANLEKE IEKLE 91.8	 42.4	 49.3	
8	 Q IDTLEAE IDQLEDE NYALETE LANLEKE IEKLE 91.9	 42.8	 49.1	
9	 K IDTLEAE IDQLEDK NYALKTE NANLEKE IEKLE 88.2	 30.6	 48.0	
10	 K IDTLKAE IDQLEDK NYALKTE LANLEKE IEKLQ 88.4	 35.9	 48.0	
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Tm and ΔTm within sequences listed in Table 1 meant that the predictive power of the software 
should be able to be validated without using the top peptide. As shown in Figure 2B – 2D, this 
potential inhibitor was not expected to form interactions with off-targets and to be able to 
outcompete all possible other complexes (satisfying the competitive and negative design 
requirements of the experiment). As shown in Figure 3, the predicted ΔTm between the closest off-
target (in this case, L–L) and the desired (L–T) complex is 50°C. The predicted Tm for the FosUisCAN-
cJun interaction (91°C) is far greater than that of the closest undesired interactions (of 40°C for the 
cJun homodimer and 41°C for the FosUisCAN homodimer). 
Figure 3 – Predicted T
m 
values of 
the isCAN selected peptide. 
FosU
isCAN
 is compared against 
previous Fos-based peptides 
targeting cJun using a cFos 
competitor (and cFos, not 
duplicating values*). All 
interactions were predicted using 
the same isCAN protocol. The ΔT
m
 
values against the highest off-
target (predicted library member homodimerisation for all but cFos). FosU
isCAN 
 is predicted to have a 
T
m
 of 91°C with a ΔT
m 
of 50°C, both of these values are the highest predicted for Fos-based peptides 
targeting cJun. 
isCAN Prediction. The isCAN selected sequence (FosUisCAN: QIDTLEA EIDQLED ENYALET 
EIANLEK EIEKLE) was predicted to be structurally optimised for maximising and minimising 
desired and non-desired interactions, as shown using helical wheel diagrams (Fig 2B-2D). For the 
negative design in avoiding formation of the FosUisCAN homodimer complex, the electrostatic 
interactions play a vital role in destabilisation. This peptide resulted in the introduction of e/g charge 
blocks6,7 which was previously shown to be important in driving intramolecular repulsion between 
neighbouring electrostatic side-chains. We previously found such charge patterns to further assist in 
concomitantly driving both favourable interactions between antagonist and target, as well as 
repulsions between potential antagonist homodimers (see also below), resulting in favourable gains 
in the measured ΔTm. The introduction of these sequence-specific changes into antagonists 
otherwise considered energetically equivalent by the bCIPA approach can provide important 
contributions; they provide both intramolecular and intermolecular electrostatic contributions to 
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stability that can concomitantly stabilise the desired state while destabilising the homodimer. This is 
because neighbouring residues of same charge act to enhance or diminish the predicted energetics 
of intermolecular e/g interactions. This means that for homodimers the intramolecular repulsions 
act to enhance the intermolecular repulsions, making the complex less stable than is predicted 
without considering e/g residue sequence context. Concomitantly, for the desired heterodimer, the 
intermolecular repulsions act to assist the intermolecular attractions to a greater extent than 
predicted without e/g sequence context. The FosUisCAN electrostatic interactions provide 
intermolecular charge blocks of 4-5 residues at g/e positions, which serves to add additional 
destabilisation to FosUisCAN homodimer while adding additional stability to the target-bound 
heterodimeric complex.  This is due to the presence of a Glu residue at both g2 and e3 – a 
combination not found in any other peptide within the top 10 from which FosUisCAN was selected. As 
shown in Table 1, many of those specific g and e positions were populated by Lys residues. For 
FosUisCAN, of the 10 possible electrostatic interactions between the residues at positions e and g, 50% 
contain favourably charged profiles (i.e. negatively charged in FosUisCAN interacting with positively 
charged residues in cJun) and 50% have non-optimal profiles (negatively charged vs. neutral charge 
or hydrophobic). E.g. e2 – g’1, g1 – e’2 and g4 – e’5 all contain electrostatically favourable salt bridge 
interactions between oppositely charged Glu – Lys. Similarly, e1 – g’0 and g3 – e’4 feature favourable 
Glu – Arg interactions.  Non-optimal profiles are a result of selection against residues native to the e 
and g positions of cJun, where negatively charged Glu is facing Ala, Gln, Thr and Gln (e’3, g’2, g’3 and 
g’4).  As shown in Table 1, inclusion of Gln at g0 for FosUisCAN is found in 3 other peptides within the 
top 10. As this position is facing a Glu at e’1 (or a Gln in all Fos family members considered as off-
targets), 6 of the peptides within the top 10 favourably target this by selecting Lys. However, Lys 
would form favourable interactions within the homodimeric complex by forming a g0 – e’1 Lys-Glu 
interaction (as in 6 other peptides found within the top 10). This is important because the cJun 
target peptide contains an Arg at g’0, meaning that the software has to decide on a g0 residue 
selection driven by the optimal interaction with this Arg while balancing potential off-target 
interactions and selecting the option that will overall contribute to the greatest ΔTm. The bCIPA 
algorithm scores an Arg-Glu interaction more favourably (-2.0) than an Arg-Gln interaction (-1.5) or 
Arg-Lys interaction (-0.5). Therefore, it is more locally beneficial to have the e1 position filled by Glu. 
Thus, to avoid favourable interactions in the homodimeric complex, it is locally favoured to populate 
g0 with Gln rather than Lys/Glu.  Although there is a high level of sequence similarity within it, there 
are no peptides within the top 10 which differ from FosUisCAN at a single residue switch at g0 to give 
full Glu at all e/g positions. What is observed instead is the introduction of Lys within different 
heptads at different peptides. This is due to the aforementioned non-optimal residues on native cJun 
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(e’3, g’2, g’3 and g’4) with Lys-Glu and Lys-Gln interactions being scored favourably (both contribute -
1.5)17,23. The Lys-Ala interaction has no associated electrostatic contribution value and this is 
discussed below. This highlights part of the conflicting design requirements that isCAN attempts to 
address.  At the core, cJun residues are optimised for hydrophobic interaction, with the a’ position 
consisting of Ile, Val, Asn, Ala and Val. FosUisCAN takes advantage of this core arrangement with Ile at 
position a (with a3 as Asn to capitalise on the oligomer limiting locus of the a3 N-N interaction25). 
Across the top 10 peptides, the major differences is a4, where 40% of the peptides are Ile and 50% 
Leu (with 1 sequence selecting Asn) facing an Ala on a’4. Both Ile/Leu contribute equally according to 
the algorithm (Ile-Ala /Leu-Ala = -0.5).  
Formation of the complex with the competitor molecule cFos is predicted to be of low stability 
(Figure 2D), from both an electrostatic and a hydrophobic standpoint. cFos core is poorly optimised 
for hydrophobic interaction (compared to transcriptionally functional cJun) due to the presence of 
multiple polar and charged Thr/Lys residues. Similarly, 60% of the cFos-FosUisCAN electrostatic 
interactions are repulsive (Glu-Glu, +0.4 kcal/mol17). Moreover, the presence of Leu at e4’ and g0’ 
positions does not allow for further beneficial electrostatic interactions.  
Circular Dichroism - An analysis of global secondary structure content for homodimeric and 
heterodimeric systems was conducted at 150 μM total peptide concentration to provide equimolar 
concentrations of each component helix for all dimeric systems. CD spectra showed FosUisCAN to exist 
as a 15.4% weakly populated helical structure (Fig 4) with the 208 nm signal significantly exceeding 
that of 222 nm. Similarly, cFos (Fig 4A) and cJun (Figure 4B) existed as 27.5% and 20.6% helical 
structures with 222/208 ratios of 0.60 and 0.82, respectively29.  
To analyse whether the selected peptide formed a complex with the cFos competitor sequence, a 
secondary structural scan of FosUisCAN – cFos was taken with CD (Fig 4A). As for component helices, 
this spectrum demonstrated the sample to lack both α-helical content (14.2%) and the double 
minima (222/208 ratio = 0.5), indicating that the two component helices are not able to associate 
into a CC. Interestingly, both monomers involved in this heteromeric system displayed greater α-
helical content when measured in isolation. 
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In contrast, the secondary structure content of the FosUisCAN – cJun containing sample (Fig 4B) 
exhibited a much more intense signal with greater α-helical content (75.1%) – almost four times the 
signal of the constituent peptides in isolation. In addition the ratio of 222/208 was 0.98, providing 
further evidence for a significant increase to the helical stability of the sample. This demonstrates 
that the incubation of cJun with FosUisCAN elicits a significant conformational change in the sample 
and provides compelling evidence for the formation of a CC30,31. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – CD spectra and thermal denaturation data. Shown are data for selected inhibitor 
peptide with cFos (a, c) and target cJun (b, d). Spectra were measured at 20°C at a total peptide 
concentration of 150 uM and presented as mean residue ellipticity (MRE). The minima at 208 nm 
and 222 nm are indicative of a helical structure, with the 222/208 ratio of the inhibitor with the cJun 
target showing more structure (222/208 = 0.98) over the undesired complex with cFos (222/208 = 
0.56). This suggests that the inhibitor preferentially heterodimerises with cJun. Thermal 
denaturation profiles of homodimeric peptides and FosUisCAN with heterodimers (c/d) were taken 
using 1°C increments and tracking the 222nm signal at 150uM. FosUisCAN shows an increase in the 
transition mid-point when in complex with cJun (d), demonstrating a Tm of 57°C compared to the off-
target state with cFos (c) which was unable to provide a measured Tm  All experiments were 
undertaken in 10 mM potassium phosphate, 100 mM potassium fluoride at pH 7. Where possible 
(d), data was fitted to the two-state model. 
A	 B	
C	 D	
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Thermal Denaturation Profiles – Having observed a significant increase in the global secondary 
structure content of the cJun- FosUisCAN sample, we next sought to (Figure 4C/D and Table S2) 
quantify the stability of the complex by undertaking thermal denaturation experiments. In 
agreement with the spectra, this pattern of increased stability between undesired and desired 
complexes was also observed using thermal melts taken in 1°C increments. FosUisCAN in isolation did 
not form a CC complex – rather only the upper baseline characteristic of the profile was observed 
(Figure 4C - black). This is in agreement with spectral data and at is indicative of a weakly populated 
helix that does not self-associate.  Further evidence for this is provided by size-exclusion 
chromatography (SEC) which demonstrates that the prominent species populated is monomeric 
(Figure 5A  - blue). When FosUisCAN is incubated with with cFos (Figure 4C - pink), the thermal 
denaturation signal is similar to that of the component peptides. In contrast, for homomeric cJun 
(Figure 4D - orange), a clear transition mid-point is visible (27°C). Similarly, SEC experiments 
demonstrated cJun to exist as a dimer in solution (Figure 5B- red). However, when cJun was 
incubated with the FosUisCAN antagonist peptide, the helical signal increasesd significantly and led to 
an increased transition midpoint of 30 °C (Figure 4D - red)– demonstrating an increase in thermal 
stability to 57°C.  This shift was further confirmed by SEC, demonstrating that the entire sample was 
in a dimeric state and that cJun had therefore paired with FosUisCAN (Figure 5B). The inability of 
FosUisCAN to form a stable homdimer in isolation is a considerable advantage, since it removes the 
presence of the homodimeric complex as a potential off-target. It is therefore only able to form a 
stable CC when combined with cJun. 
Figure 5 – Size Exclusion 
Chromatography Experiments. 
Shown are SEC profiles for post-
melt samples. (A): Peaks at 
approximately 19.3 min and 
21.3 min representing a mixture 
of dimer and monomer 
respectively, in the FosUisCAN-cFos mixture (dark blue). Component cFos and FosUisCAN homodimer 
peaks show larger monomeric peaks compared to dimeric peaks. (B): FosUisCAN – cJun mixture 
generated a broad peak at approximately 19.3 with constituent cJun homodimer generating a peak 
at approximately 19.5 min, both indicating a dimer. Arrows show previously characterised controls 
on 39-mer peptides*. 
 
A	 b	B	
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The difference between the experimental thermal stability values and the values predicted by isCAN 
(Fig 3 vs Fig 6) is of interest. Observing the desired complex FosUisCAN – cJun, there was a decrease of 
34°C between the predicted and experimental values. This is similar for 4hFosW and 4hFosW-cJun24, 
where the complex was measured to be 16-17°C higher than bCIPA predicted. However, there was 
an observed decrease in the stability of the predicted extended cJun-cJun interaction which, 
combined with the off-target complexes, was not found to form a stable interaction. Overall, this 
means that the ΔTm value has dropped reduced from 50°C predicted to 30°C when measured. 
Although a significant decrease, the measured value represents a bigger different between desired 
state stability and nearest off-target stability than that for any previous inhibitor peptide we have 
developed. Previous work exploring the further biophysical characteristics of peptides with similar 
thermal stability through isothermal calorimetry24 gives insight into the importance of this 
difference. FosW-cJun (Tm = 63°C) displayed a Kd value of 39 nM whereas 20HC – cJun (Tm = 33°C) 
displayed a Kd of 15 μM. Since this has a similar thermal stability to the FosUisCAN – cJun interaction 
and the closest off target, cJun-cJun, we can estimate that the 30°C ΔTm value denotes a sizable shift 
in the Kd from the range of nM (desired state) to μM (off-target states)3,24.  
Figure 6. Measured T
m 
values of the 
isCAN selected peptide. A 
comparison of measured FosUisCAN 
with previously designed peptides 
FosW, FosWCANDI and 4hFosW. The Tm 
of the cJun-FosUisCAN was measured as  
57°C with a ΔTm of 30°C from the 
cJun-cJun homodimer Tm of 27°C. 
xNeither the FosUISCAN nor mixture 
with cFos was found to form dimers, 
with the thermal denaturation profile 
unable provide a measured Tm (Tm < 0°C).  +4hFosW-cFos thermal denaturation data is missing. 
(4hFosW homodimer data previously unpublished). 
 
bCIPA Screening - The discrepancies between Tm values predicted by isCAN and the measured values 
validated through CD suggest that predictions are overestimating the stability of some complexes, 
which are generally higher than experimentally measured thermal melts. A simple reason for this is 
the scope of the underlying bCIPA and how it was developed. Using the interaction profiles of 45 
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peptides (and tested on 592 interactions), it means that bCIPA has a wide scope for predicting 
peptide interactions3. However, there are some instances in which the algorithm does not have the 
required data to estimate a contribution to binding affinity. For example, a Lys-Ala is not estimated 
to make a contribution. Compared to a known and quantified interaction, it is an example of a non-
optimal interaction. In comparison to interactions that are known to be non-favourable (and thus 
positively scored), a value of 0 is seen as more favourable – although it represents a lack of data. This 
may explain some of the discrepancies in predicted/actual Tm values observed, with the 
incorporation of energetically non-favourable interactions. This is mitigated somewhat by the 
inclusion of the helical propensity values that each residue contributes – meaning that if the 
electrostatic contributions assumed within the algorithm are incorrect, there are other parameters 
that the algorithm uses to select residues. 
From a software development perspective, the version used within this work stores all of the library 
sequences within the memory of the program, as well as data generated by interaction calculations. 
Further development is ongoing, with the goal of minimising the amount of data stored within the 
active program at any one point. It is hoped that this will limit the computational expense of this 
software and remove an obstacle in scaling up for high-performance systems. This would allow the 
isCAN approach to be used with larger systems and increased numbers of off-target peptides. Other 
in silico approaches with peptides have made use of other forms of searching within a large data set 
(including genetic algorithms32 and Monte Carlo methods33). These methods of searching are 
typically coupled with molecular dynamics and docking simulations. If applied to a pairwise search 
with appropriate methodology, this could be a novel way to further screen for suitable peptides. 
Moreover, as we have previously demonstrated6, bCIPA can be trained for specific bZIP subsets to 
increase its accuracy in such systems. Where knowledge of binding affinities is scarcer and more 
accuracy is required, an approach could be employed where exploratory experiments are conducted 
and the data used to create the necessary bespoke training/test sets. This could allow the predictors 
within the algorithm to be adjusted accordingly for the bZIP profile.  
Limitations of Pairwise-Approach - It has been suggested that the interaction of residues might not 
be limited to the pairwise model that bCIPA uses19. Experiments that computationally derive 
additional scoring mechanisms from reported interaction affinities found that “triplet scoring” – the 
concept that the combinations of 3 residues at contact positions between a, d, e and g – could play a 
role in the prediction of coiled coil interaction.19 Evidence that a combination of pairwise and triplet 
predictors increase accuracy provides further support for our “charge block” concept (blocks of 
same charge electrostatic residues at e and/or g postions)6,7.  The charge block observations 
correlate to more nuanced, context specific stabilisation due to g/e residues interacting with a/d 
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residues to modify total interaction, the underlying algorithm could be improved to reflect this. As 
described above, previous work on peptides of a particular profile6 has shown that training the 
algorithm on similar sequences has further optimised the weighting of the predictors to better 
predict Tm values. Since our studies have focused on Fos/Jun family bZIPs, a similar technique could 
be applied here. However, the lower Tm from predicted to measured values is consistent across the 
many FosUISCAN interactions studied in this system. This suggests that, although non-optimal for our 
elongated peptides, the software is still able to correctly predict Tm relationships. In comparison with 
previous work in this field – peptides generated solely through PCA and CANDI3,13 – this marks 
significant progress.  As can be seen in Figure 6, although there is less than 10°C between the 
predicted Tm of  cJun-4hFosW and cJun-FosUisCAN, there is a measured increase of 17°C in the ΔTm, 
making FosUisCAN much more specific than 4HFosW for cJun relative to Fos. This value – indicative of 
the ability to design against negative and competitive states – while maximising desired state 
stability shows the real strength of the isCAN technique. Our aim was to create a competitive binder 
for cJun which, through high-throughput computational screening, would address conflicting design 
requirements between desired and undesired states. The increased ΔTm of FosUisCAN relative to 
previously designs, coupled with a high thermal stability with cJun, supports our initial hypothesis 
that in silico screening of peptides to mimic and control the parameters of a PCA-CANDI can result in 
peptides that can selectively inhibit cJun without interacting with cFos or other off-target bZIPs. The 
off-targets are then free to form transcriptionally active components of AP-1. Future exploration into 
combining this approach with an in cellulo PCA-CANDI would be the next step in validating and 
potentially generating useful antagonists for future peptide therapies targeting not only AP-1 
dysregulation but any complex bZIP – mediated pathway in disease. This approach would provide a 
best-of-both combination of utilising very large libraries, screening via a computational approach to 
enrich for predicted binders with the desired attributes of high affinity and selectively, and then 
finally to experimentally screen the resulting reduced-size high quality library that is accessible to 
intracellular selection systems.  
In conclusion, our work provides a framework by which bZIPs can be modelled within a CANDI 
environment with accuracy to derive highly selective peptide sequences. Driving the approach with a 
solely computational and data-driven framework allows us to collect data about peptide-peptide 
interactions and specificity both within and between bZIP families. As more and more experimental 
data becomes readily available, this approach will become increasingly valuable in the design of 
specific peptides that can target key components within increasingly complex bZIP interactomes. 
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